Gemalto SafeNet KeySecure integration with NetApp provides centralized key management for thousands of volumes across multiple clusters

AMSTERDAM -Tuesday, April 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today announced that SafeNet KeySecure has been validated for use with the latest release of NetApp® Volume Encryption (NVE) data management solution. As a result, NetApp customers do not need to encrypt the entire disk drive; they can choose to encrypt granularly at the volume level without the need and additional cost of purchasing self encrypting drives (SEDs), while retaining key benefits such as centralized key management and access control, better compliance, and high availability.

Data privacy and data security continues to be a key focus for organizations, especially in light of industry compliance standards such as US health standard (HIPAA) or payment card standard (PCI-D ... Read more »

SAN DIEGO-Tuesday, April 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today.

As CTO, Ghoshal will lead ResMed’s global healthcare informatics and data analytics team to drive its world-leading cloud-based digital health platforms as well as investments in emerging health technologies like artificial intelligence and machine learning.

Ghoshal has more than 25 years’ experience in information technology, semiconductor innovation, digital strategy, information security, advanced analytics, operations and customer care. Since 2016, Ghoshal has been chief operating officer at Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care. From 2012 to 2016, he was vice president of information technology at ResMed. Previously, Ghoshal worked in a number of management and technical roles in the semic ... Read more »

DAEJEON, South Korea-Monday, April 2nd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma Multiforme.”

“We are very pleased with this Orphan Drug Designation from FDA for TTAC-0001 for GBM treatment since we have been preparing for clinical studies of TTAC-0001 plus KEYTRUDA® (pembrolizumab) combo therapy for recurrent GBM in addition to TTAC-0001 mono therapy for recurrent GBM progressed after bevacizumab treatment. It will accelerate the progress of TTAC-0001 to provide clinical benefit in the treatment of GBM,” said Dr. Jin-San Yoo, president and chief executive officer of PharmAbcine, Inc.

The FDA Office of Orphan Products Development grants Orphan Dr ... Read more »

TOKYO-Monday, April 2nd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Nobuaki Kurumatani today took office as the first Chairman and CEO of Toshiba Corporation (TOKYO:6502) to be appointed from outside the company in over 50 years.

Commenting on his appointment as Representative Executive Officer and Chairman and CEO, Mr. Kurumatani said, “I am honored to be appointed CEO, and very much aware of the responsibilities I take on. Toshiba is not just any company. Its corporate DNA has realized countless Japan- and world-first technologies and products, made Toshiba a source of pride in Japan for nearly 145 years, and also made us a global leader.

“I believe that helping Toshiba back on its feet is my true calling. I am here at Toshiba to support change and transformation, and I see my role as to build on the company’s resilience and to lead its recovery. To secure growth, we must radically improve our earning power and reinforce our finances. We must m ... Read more »

PARIS-Thursday, March 29th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Today Huawei Consumer Business Group unveiled the HUAWEI P20 Series. The HUAWEI P20 Pro features the world’s first Leica triple camera and both devices include unprecedented AI advances, combining technology and art to bring to life a groundbreaking smartphone experience.

 “We look for inspiration from artists to continuously evolve our approach to design and innovation,” said Richard Yu, Chief Executive Officer, Huawei Consumer Business Group. “With a breakthrough triple camera on the HUAWEI P20 Pro, an advanced dual camera on the HUAWEI P20 and powerful artificial intelligence on both, today’s most vibrant consumers can capture and share the brilliance of the world around them.”

Key features of the HUAWEI P20 Series include:

An advanced camera to capture more light, featuring a Leica triple camera and 5x Hybrid Zoom on the HUAWEI P20 Pro, and a ... Read more »